MMSI

84.3400.08%
MG

Martha Goldberg Aronson

President, CEO & Director

Ms. Martha Goldberg Aronson is President and Chief Executive Officer at Merit Medical Systems, Inc. since July 7, 2025. Ms. Aronson also serves as Director at Merit Medical System, inc. from October 3, 2025. She served as an Independent Chair of the Board of CONMED Corporation since October 31, 2024 until May 21, 2025. She served as an Independent Director of CONMED Corporation since February 23, 2016 until July 7, 2025 and served as its Lead Independent Director since May 21, 2020 until October 31, 2024. She was Director of Bright Uro, Inc. since October 2024 until October 2025. She served as Chief Executive Officer and President of Beta Bionics, Inc. and served as its Director. Ms. Aronson served as Chair of the Board at Beta Bionics, Inc. from February 9, 2021 to March 2022 and served as its Interim Chief Executive Officer since March 2022 and Independent Director from February 20, 2020 to March 2022. Ms. Aronson serves as Independent Director at Clinical Innovations LLC through December 2019. Ms. Aronson served as an Executive Vice President and President of Global Healthcare at Ecolab Inc. from September 2012 to April 2016, where she was responsible for the global healthcare business with a specific focus on products and programs for infection prevention. Ms. Aronson has extensive leadership experience in publicly traded companies in the med-tech industry. She served as the President of North America and Senior Vice President of Hill-Rom Holdings, Inc. from August 2, 2010 to May 2012. Prior to Hill-Rom, she spent at Medtronic, Inc. She served as the Chief Talent Officer and Senior Vice President of Medtronic, Inc., (alternate name Medtronic plc) since March 2008. She joined Medtronic, Inc. in 1991, first working in corporate development and strategic planning as a business Analyst. At Medtronic, Inc., Ms. Aronson served as Vice President of Investor Relations from May 2006 to March 2008, Vice President of the Neurological, Gastroenterology/Urology, Obesity Management, ENT/Neurologic Technology and Diabetes businesses in Western Europe from May 2003 to May 2006 and Vice President and General Manager of Medtronic Gastroenterology/Urology from 2001 to May 2003. She served as corporate officer for Medtronic, Inc. Ms. Aronson also held several Managerial positions at Medtronic in marketing and product management. She was an Associate Consultant at Bain & Company, Inc. She has been an Independent Director of Cardiovascular Systems, Inc. since February 21, 2017. She had been a Director of Methode Electronics, Inc. since April 19, 2016 until September 2019. She is Chairman of the Board of the Guthrie Theater. She served as an Independent Director at Hutchinson Technology Inc. from June 2010 to October 5, 2016. She is a Member of the Minnesota Women's Economic Roundtable and the Wellesley College Business Leadership Council and serves on the boards of the Minnesota Opera and the Minneapolis Club. Ms. Aronson received her Master of Business Administration from Harvard Business School and a Bachelor of Arts in Economics from Wellesley College, graduating magna cum laude and Phi Beta Kappa.

Positions